Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Fritz, Leutmezer"'
Autor:
Tobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, Renate Thalhammer, Helmuth Haslacher, Patrick Altmann, Barbara Kornek, Nik Krajnc, Tobias Monschein, Christiane Schmied, Karin Zebenholzer, Gudrun Zulehner, Thomas Berger, Paulus Rommer, Fritz Leutmezer, Gabriel Bsteh
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundRecent studies proposed cellular immunoprofiling as a surrogate for predicting treatment response and/or stratifying the occurrence of adverse events (AEs) in persons with multiple sclerosis (pwMS). However, applicability in real-world circ
Externí odkaz:
https://doaj.org/article/f1da4e070204403483fdf521afd7941e
Publikováno v:
Brain and Behavior, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Background and purpose Randomized controlled trials and observational studies of nabiximols oromucosal spray in patients with multiple sclerosis (MS) spasticity have shown improvement in a range of associated symptoms (pain, spasms, fatigue,
Externí odkaz:
https://doaj.org/article/56b987ad75cc44da85548cded692f9e7
Autor:
Alexandra Lipka, Wolfgang Bogner, Assunta Dal-Bianco, Gilbert J. Hangel, Paulus S. Rommer, Bernhard Strasser, Stanislav Motyka, Lukas Hingerl, Thomas Berger, Fritz Leutmezer, Stephan Gruber, Siegfried Trattnig, Eva Niess
Publikováno v:
NeuroImage: Clinical, Vol 40, Iss , Pp 103524- (2023)
Objective: To investigate the metabolic pattern of different types of iron accumulation in multiple sclerosis (MS) lesions, and compare metabolic alterations within and at the periphery of lesions and newly emerging lesions in vivo according to iron
Externí odkaz:
https://doaj.org/article/a971edbb91f94e1fafa2e701bd7862da
Autor:
Jakob Rath, Olivia Foesleitner, Lukas Haider, Hubert Bickel, Fritz Leutmezer, Stephan Polanec, Michael A. Arnoldner, Gere Sunder-Plassmann, Daniela Prayer, Thomas Berger, Paulus Rommer, Gregor Kasprian
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Objective White matter lesions (WML) in multiple sclerosis (MS) differ from vascular WML caused by Fabry disease (FD). However, in atypical cases the discrimination can be difficult and may vary between individual raters. The aim of this stu
Externí odkaz:
https://doaj.org/article/3e59fa5202b14284986fd5ac7c0a2641
Autor:
Theresa König, Fritz Leutmezer, Thomas Berger, Alexander Zimprich, Christiane Schmied, Elisabeth Stögmann, Tobias Zrzavy
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 14, p 11254 (2023)
Multiple Sclerosis (MS) is a common immune-mediated disorder of the central nervous system that affects young adults and is characterized by demyelination and neurodegeneration. Recent studies have associated C9orf72 intermediate repeat expansions wi
Externí odkaz:
https://doaj.org/article/c86f6f585a64453197323524211df0e0
Autor:
Patrick Altmann, Markus Ponleitner, Tobias Monschein, Nik Krajnc, Gudrun Zulehner, Tobias Zrzavy, Fritz Leutmezer, Paulus Stefan Rommer, Barbara Kornek, Thomas Berger, Gabriel Bsteh
Publikováno v:
Digital Health, Vol 8 (2022)
Background Monitoring of patient outcomes in multiple sclerosis (MS) is fundamental for individualized treatment decisions. So far, these decisions have been motivated by conventional outcomes, i.e., relapses or clinical disability supported by radio
Externí odkaz:
https://doaj.org/article/ad0b53cf7ffd40d78ff77ddb37e06879
Autor:
Patrick Altmann, Fritz Leutmezer, Markus Ponleitner, Dominik Ivkic, Nik Krajnc, Paulus Stefan Rommer, Thomas Berger, Gabriel Bsteh
Publikováno v:
Digital Health, Vol 8 (2022)
Introduction Continuous monitoring is the hallmark of managing chronic disease. Multiple sclerosis (MS), in particular, requires patients to visit their treating neurologists typically twice a year, at least. In that respect, the COVID-19 pandemic ma
Externí odkaz:
https://doaj.org/article/01862792a0704d38aa7c4bcd940634f5
Autor:
Patrick Altmann, Markus Ponleitner, Paulus Stefan Rommer, Helmuth Haslacher, Patrick Mucher, Fritz Leutmezer, Axel Petzold, Christoph Wotawa, Rupert Lanzenberger, Thomas Berger, Henrik Zetterberg, Gabriel Bsteh
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Neurofilament light chain (NfL) has emerged as a biomarker of neuroaxonal damage in several neurologic conditions. With increasing availability of fourth-generation immunoassays detecting NfL in blood, aspects of pre-analytical stability of
Externí odkaz:
https://doaj.org/article/358a90b1ab554193b676f82369723acf
Autor:
Michael Guger, Michael Matthias Ackerl, Martin Heine, Christiane Hofinger-Renner, Heinrich Karl Spiss, Andrea Taut, Karin Unger, Fritz Leutmezer
Publikováno v:
eNeurologicalSci, Vol 27, Iss , Pp 100396- (2022)
Objectives: A prospective, multicenter, open-label, noninterventional study assessed the efficacy, safety, tolerability, and patient satisfaction with teriflunomide therapy over a 24-month follow-up period under real-world conditions in Austria. Meth
Externí odkaz:
https://doaj.org/article/3f46d3cfc3044fd68d8129384248e79a
Autor:
Nik Krajnc, Gabriel Bsteh, Gregor Kasprian, Tobias Zrzavy, Barbara Kornek, Thomas Berger, Fritz Leutmezer, Paulus Rommer, Hans Lassmann, Simon Hametner, Assunta Dal-Bianco
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Background:Iron rim lesions (IRLs) represent chronic lesion activity and are associated with a more severe disease course in multiple sclerosis (MS). How the iron rims around the lesions arise in patients with MS (pwMS), and whether peripheral hemoly
Externí odkaz:
https://doaj.org/article/a209c95a350e461a8e3df79065b3753d